PHARMACEUTICALLY CONTROLLED RELEASE OF BEADS COMPRISING FUROSEMIDE AND A FORMULATION CONTAINING SAID CONTROLLED RELEASE BEADS

• 1. 包含水难溶性药物的聚合物胶束制剂的体外释放试验及评价方法 [P] . 中国专利： CN109475498B . 2021.04.02
• 2. 包含可断裂化学键载药胶束的药物释放过程的模拟方法 [P] . 中国专利： CN109686409B . 2020.08.18
• 3. Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads [P] . ZA9610888B . 1997-07-07

  机译： 包含速尿的药物控释珠和含有所述控释珠的制剂

• 4. PHARMACEUTICAL CONTROLLED RELEASE BEADS COMPRISING FUROSEMIDE AND A FORMULATION CONTAINING SAID CONTROLLED RELEASE BEADS [P] . 世界知识产权组织专利： WO9725028A1 . 1997-07-17

  机译： 包含呋喃酮化物和包含所述受控受控释放珠的配方的药物受控释放珠

• 5. Pharmaceutical controlled release beads comprising furosemide and a formulation containing said controlled release beads [P] . AU1323897A . 1997-08-01

  机译： 包含速尿的药物控释珠和含有所述控释珠的制剂

• 1. Design and in vitro evaluation of controlled release alginate beads of diltiazem hydrochloride [J] . D.Nagasamy Venkatesh, A.Kalaivani, Kritika D.Kalro, 亚太热带医药杂志（英文版） . 2009,第004期
• 2. Efficacy and safety of controlled-releaser oxycodone/naloxone versus controlled-release oxycodone in Korean patientsr with cancer-related pain: a randomized controlled trial [J] . Kyung-Hee Lee, Min Kyoung Kim, Yong Sang Hong, 癌症（英文版） . 2017,第011期
• 3. Formulation development of nifedipine controlled-release coated tablets [J] . Ananya Ubonratana, Sirachaya Choosakul, Nara Nilnakara, 亚洲药物制剂科学(英文) . 2016,第001期
• 4. FORMULATION OF CONTROLLED RELEASE BEADS CONTAINING VERAPAMIL HCI: SCREENING OF PROCESS AND FORMULATION VARIABLES [C] . S. Vaithiyalinqam, I. K. Reddy, M. A. Khan International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001
• 5. 1. Development of hot-melt pan-coating, application to sustained-release capsules and tamper resistant-coating. 2. Formulation of verapamil hydrogen chloride and diltiazem hydrogen chloride semisolid matrix capsules. 3. Novel sustained release tablet of glipizide: Compression of coated drug beads, formulation, dissolution, and convolution. 4. Verapamil sustained release: New formulation and convolution. [D] . Nguyen, Chien Ngoc. 2006
• 6. Development of orally disintegrating tablets comprising controlled-release multiparticulate beads [O] . Gopi M. Venkatesh, Phillip J. Stevens, Jin-Wang Lai -1
• 7. Development of orally disintegrating tablets comprising controlled-release multiparticulate beads [O] . Gopi M. Venkatesh, Phillip J. Stevens, Jin-Wang Lai 2012
• 8. Controlled Release of Bioactive Materials Using Alginate Gel Beads [R] . Connick, W. J. 1980

• 1. Alginate Reinforced Chitosan and Starch Beads in Slow Release Formulation of Imazaquin Herbicide—Preparation and Characterization [J] . Lami A. Nnamonu ,Rufus Sha’Ato ,Ikenna Onyido . 材料科学与应用期刊（英文） . 2012,第8期
• 2. Development of controlled release formulations of thiabendazole [J] . Yasser Z. El-Nahhal . 农业化学和环境（英文） . 2014,第1期
• 3. 去PEG屏蔽的还原敏感聚氨酯胶束用于抗肿瘤药物控制释放 [C] . 朱彩虹 ,过倩萍 ,李玉玲 . 2017中国生物材料大会 . 2017
• 4. 基于聚聚(N-异丙基丙烯酰胺)的温敏胶束的制备、胶束化行为及药物体外释放的研究 [A] . 谭松巍 . 2011